申请人:Taiho Pharmaceutical Company Limited
公开号:US04293713A1
公开(公告)日:1981-10-06
A novel 1,1,3,5-substituted biuret compound of the formula: ##STR1## wherein R.sup.1 and R.sup.2 are respectively the same or different, and each are alkyl groups having 1 to 4 carbon atoms; R.sup.3 is a cyclohexyl group or a phenyl group which may be unsubstituted or may have at least one substituent selected from the group consisting of chlorine, bromine, fluorine, methyl, trifluoromethyl, dimethylamino, methoxy, methylthio, nitro and acetyl. The novel 1,1,3,5-substituted biuret compounds are useful as an analgesic, anti-inflammatory and/or anti-pyretic agent.
一种新颖的1,1,3,5-取代的双脲化合物,化学式如下:##STR1##其中R.sup.1和R.sup.2分别相同或不同,且均为含有1至4个碳原子的烷基基团;R.sup.3为环己基基团或苯基基团,可以是未取代的,也可以具有至少一种来自氯、溴、氟、甲基、三氟甲基、二甲胺基、甲氧基、甲硫基、硝基和乙酰基的取代基。这种新颖的1,1,3,5-取代的双脲化合物可用作镇痛剂、抗炎和/或退热剂。